Tumor necrosis factor and clinical and metabolic courses after cardiac surgery in children

Journal of Thoracic and Cardiovascular Surgery

Volumn 124, Issue 5, 2002, Pages 991-998

  Sason Ton, Yokrat ^a   Ben Abraham, Ron ^a   Lotan, Danny ^a   Dagan, Ovadia ^a   Prince, Tal ^a   Barzilay, Zohar ^a   Paret, Gideon ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

ACID BASE BALANCE; ACIDOSIS; ADOLESCENT; ANESTHESIA INDUCTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; EXTRACORPOREAL CIRCULATION; FEMALE; GENERAL ANESTHESIA; HEART HEMODYNAMICS; HEART SURGERY; HEMODYNAMIC MONITORING; HIGH RISK POPULATION; HUMAN; INFANT; MALE; PEDIATRIC SURGERY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036828755     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2002.124391     Document Type: Article

References (43)

1. Strieter RM, Kunkel SL, Bone RC. Role of tumor necrosis factor-α in disease states and inflammation. Crit Care Med. 1993;21 Suppl:S447-63.
2. Strieter RM, Lukacs NW, Standiford TJ, Kunkel SL. Cytokines 2: Cytokines and lung inflammation: Mechanisms of neutrophil recruitment to the lung. Thorax. 1993;48:765-9.
3. Okusawa S, Yancey KB, van der Meer JW, Endres S, Lonnemann G, Hefter K. et al. C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro: Comparison with secretion of interleukin 1β and interleukin 1α. J Exp Med. 1988;168:443-8.
4. Movat HZ. Tumor necrosis factor and interleukin-1: Role in acute inflammation and microvascular injury. J Lab Clin Med. 1987;110:668-81.
5. Casey LC. Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg. 1993;56 Suppl:S92-6.
6. Tracey KJ, Cerami A. Tumor necrosis factor: An updated review of its biology. Crit Care Med. 1993;21 Suppl:S415-22.
7. Casey WF, Hauser GJ, Hannallah RS, Midgley FM, Khan WN. Circulating endotoxin and tumor necrosis factor during pediatric cardiac surgery. Crit Care Med. 1992;20:1090-6.
8. Baufreton C, Moczar M, Intrator L, Jansen PG, te Velthuis H, Le Besnerais P, et al. Inflammatory response to cardiopulmonary bypass using two different types of heparin-coated extracorporeal circuits. Perfusion. 1998;13:419-27.
9. Deng MC, Wiedner M, Erren M, Mollhoff T, Assmann G, Scheld HH. Arterial and venous cytokine response to cardiopulmonary bypass for low risk CABG and relation to hemodynamics. Eur J Cardiothorac Surg. 1995;9:22-9.
10. Steinberg JB, Kapelanski DP, Olson JD, Weiler JM. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1993;106:1008-16.
11. Butler J, Parker D, Pillai R, Westaby S, Shale DJ, Rocker GM. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg. 1993;105:25-30.
12. Holzheimer RG, Molloy RG, Gorlach H, Wilkert S, Hehrlein F. IL-6 and TNF a release in association with neutrophil activation after cardiopulmonary bypass surgery. Infection. 1994;22:37-42.
13. Markewitz A, Faist E, Lang S, Endres S. Hultner L, Reichart B. Regulation of acute phase response after cardiopulmonary bypass by immunomodulation. Ann Thorac Surg. 1993;55:389-94.
14. Kawamura T, Wakusawa R, Okada K, Inada S. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: Participation of interleukin 8 and 6 in reperfusion injury. Can J Anaesth. 1993;40:1016-21.
15. Levy JH, Kelly AB. Inflammation and cardiopulmonary bypass. Can J Anaesth. 1993;40:1009-15.
16. Marti F, Munoz J, Peiro M, Bertran E, Ferran C, Octavio C, et al. Higher cytotoxic activity and increased levels of IL-1b, IL-6, and TNF a in patients undergoing CPB. Am J Hematol. 1995;49:237-9.
17. Lahat N, Zlotnick AY, Shtiller R, Bar I, Merin G. Serum levels of IL-1, IL-6 and tumor necrosis factor in patients undergoing coronary artery bypass grafts or cholecystectomy. Clin Exp Immunol. 1992;89:255-60.
18. Charpie JR, Dekeon MK, Goldberg CS, Mosca RS, Bove EL, Kulik TJ. Serial blood lactate measurements predict early outcome after neonatal repair or palliation for complex congenital heart disease. J Thorac Cardiovasc Surg. 2000;120:73-80.
19. Cheifetz IM, Kern FH, Schulman SR, Greeley WJ, Ungerleider RM, Meliones JN. Serum lactate correlates with mortality after operations for complex congenital heart disease. Ann Thorac Surg. 1997;64:735-8.
20. Munoz R, Laussen PC, Palacio G, Zienko L, Piercey G, Wessel DL. Changes in whole blood lactate levels during cardiopulmonary bypass for surgery for congenital cardiac disease: An early indicator of morbidity and mortality. J Thorac Cardiovasc Surg. 2000;119:155-62.
21. Jansen NJ, van Oeveren W, van den Broek L, Oudemans-van Straaten HM, Stoutenbeek CP, Joen MC, et al. Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. J Thoracic Cardiovasc Surg. 1991;102:515-25.
22. Oudemans-van Straaten HM, Jansen PG, te Velthuis H, Beenakkers IC, Stoutenbeek CP, van Deventer SJ, et al. Increased oxygen consumption after cardiac surgery is associated with the inflammatory response to endotoxemia. Intensive Care Med. 1996;22:294-300.
23. Khabar KS, el Barbary MA, Khouqeer F, Devol E, al-Gain S, alHalees Z. Circulating endotoxin and cytokines after cardiopulmonary bypass: Differential correlation with duration of bypass and systemic inflammatory response/multiple organ dysfunction syndromes. Clin Immunol Immunopathol. 1997;85:97-103.
24. Pilz G, Fraunberger P, Appel R, Kreuzer E, Werdan K, Walli A, et al. Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis using soluble tumor necrosis factor receptor-p55 concentrations. Crit Care Med. 1996;24:596-600.
25. Saatvedt K, Lindberg H, Geiran OR, Michelsen S, Aasen AO, Pedersen T, et al. Complement activation and release of tumor necrosis factor alpha, interleukin-2, interleukin-6 and soluble tumor necrosis factor and interleukin-2 receptors during and after cardiopulmonary bypass in children. Scand J Clin Lab Invest. 1995;55:79-86.
26. Denizot Y, Feiss P, Nathan N. Are lipids mediators implicated in the production of pro- and anti-inflammatory cytokines during cardiopulmonary bypass graft with extracorporeal circulation? Cytokine. 1999; 1:301-4.
27. Finn A, Naik S, Klein N, Levinsky RJ, Strobel S, Elliott M. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1993;105:234-41.
28. Andersen LW, Landow L, Baek L, Jansen E, Baker S. Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor-alpha concentrations in patients undergoing cardiopulmonary bypass. Crit Care Med. 1993;21:210-7.
29. Ito H, Hamano K, Gohra H, Katoh T, Fujimura Y, Tsuboi H, et al. Relationship between respiratory distress and cytokine response after cardiopulmonary bypass. Surg Today. 1997;27:220-5.
30. Lilic D, Cant AJ, Abinun M, Calvert JE, Spickett GP. Cytokine production differs in children and adults. Pediatr Res. 1997;42:237-40.
31. Hattler BG, Oddis CV, Zeevi A, Luss H, Shah N, Geller DA, et al. Regulation of constitutive nitric oxide synthase activity by the human heart. Am J Cardiol. 1995;76:957-9.
32. Brix-Christensen V, Tonnesen E, Sorensen IJ, Bilfinger TV, Sanchez RG, Stefano GB. Effects of anaesthesia based on high versus low doses of opioids on the cytokine and acute-phase protein responses in patients undergoing cardiac surgery. Acta Anaesthesiol Scand. 1998;42:63-70.
33. Kotani N, Hashimoto H, Sessler DI, Yashuda T, Ebina T, Muraoka M, et al. Expression of genes for proinflammatory cytokines in alveolar macrophages during propofol and isoflurane anesthesia. Anesth Analg. 1999;89:1250-6.
34. Wang W, Huang HM, Zhu DM, Chen H, Su ZK, Ding WX. Modified ultrafiltration in paediatric cardiopulmonary bypass. Perfusion. 1998; 13:5,304-10.
35. Wang MJ, Chiu IS, Hsu CM, Wang CM, Lin PL, Chang CI, et al. Efficacy of ultrafiltration in removing inflammatory mediators during pediatric cardiac operations. Ann Thorac Surg. 1996;61:651-6.
36. Millar AB, Armstrong L, van der Linden J, Moat N, Ekroth R, Westwick J, et al. Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg. 1993;56:1499-502.
37. Teoh KH, Bradley CA, Gauldie J, Burrows H. Steroid inhibition of cytokine-mediated vasodilatation after warm heart surgery. Circulation 1995;92 Suppl:11347-53.
38. Wherry JC, Pennington JE, Wenzel RP. Tumor necrosis factor and the therapeutic potential of anti-tumor necrosis factor antibodies. Crit Care Med. 1993;21 Suppl:S436-40.
39. Vertrees RA, Tao W, Kramer GC, Nutt L, McDaniel LB, DeVine SD, et al. Tumor necrosis factor monoclonal antibody prevents alterations in leukocyte populations during cardiopulmonary bypass. ASAIO J. 1994;40:M554-9.
40. Tabardel Y, Duchateau J, Schmartz D, Marecaux G, Shahla M, Barvais L, et al. Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men. Surgery. 1996;119:76-80.
41. Nicod LP. Cytokines 1: Overview. Thorax. 1993;48:660-7.
42. Hill GE. Cardiopulmonary bypass-induced inflammation: Is it important? J Cardiothorac Vasc Anesth. 1998;12 Suppl 1:21-5.
43. Carney DE, Lutz CJ, Picone AL, Gatto LA, Schiller HJ, Finck CM, et al. Soluble tumor necrosis factor receptor prevents post-pump syndrome. J Surg Res. 1999;83:113-21.